Compounds That Target MET

MET proto-oncogene, receptor tyrosine kinase · 79 compounds in BiohacksAI corpus

MET (MET proto-oncogene, receptor tyrosine kinase) is a biological target with 79 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MET modulation for therapeutic and biohacking applications.

View MET target page →UniProt: P08581 ↗

Most Studied Compounds for MET

Crizotinib

298+

studies

All 50 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Epigalocatechin Gallate

5.40

confidence

Sb 203580

4.92

confidence

Cabozantinib

4.39

confidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Vandetanib

4.30

confidence

Ceritinib

4.19

confidence

Bosutinib

4.08

confidence

Bi 2536

4.01

confidence

Epicatechin Gallate

3.95

confidence

Crizotinib

298+

studies

3.93

confidence

Midostaurin

3.85

confidence

Brigatinib

3.81

confidence

Pazopanib

3.69

confidence

Neratinib

3.66

confidence

Nintedanib

3.61

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Bms 387032

3.47

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Bms 777607

3.37

confidence

Linifanib

3.33

confidence

Dabrafenib

3.30

confidence

Jnj 7706621

3.09

confidence

At 9283

3.09

confidence

Gallocatechin Gallate

3.09

confidence

Lestaurtinib

3.04

confidence

Defosbarasertib

2.89

confidence

R 406

2.83

confidence

Cediranib

2.83

confidence

Pf 00562271

2.77

confidence

Infigratinib

2.77

confidence

Pha 665752

2.71

confidence

Jnj 38877605

2.71

confidence

Kw 2449

2.64

confidence

Tivozanib

2.64

confidence

Linsitinib

2.64

confidence

Bemcentinib

2.64

confidence

Pf 04217903

2.64

confidence

Ast 487

2.56

confidence

Raf 265

2.48

confidence

Merestinib

2.48

confidence

Poziotinib

2.48

confidence

Tak 285

2.40

confidence

Bms 754807

2.30

confidence

Sgx 523

2.30

confidence

Rigosertib

2.30

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MET (MET proto-oncogene, receptor tyrosine kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MET target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.